Metraipolis › archive › dc_b4057aceeb47
Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness-A Pilot Study — Europe PMC PMID:41828032
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41828032
- DOI
- 10.3390/diagnostics16050758
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T04:17:35.490Z
- SHA-256 of the archived text
37f3b54dd2bf5650481b36733e84ddd8690b9f428123a8d6940ee06a39ff77af- Stable URL of this page
https://metraipolis.com/documento/dc_b4057aceeb47
How to cite
Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness-A Pilot Study — Europe PMC PMID:41828032 — Europe PMC (en), https://europepmc.org/article/MED/41828032 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4057aceeb47 (Metraipolis archive dc_b4057aceeb47, sha256 37f3b54dd2bf5650481b36733e84ddd8690b9f428123a8d6940ee06a39ff77af)
BibTeX
@misc{dcb4057aceeb47,
title = {Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness-A Pilot Study — Europe PMC PMID:41828032},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41828032},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4057aceeb47; sha256 37f3b54dd2bf5650481b36733e84ddd8690b9f428123a8d6940ee06a39ff77af},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828032. Agents can read the archived copy with the MCP tool read_document.